Daily Stock List
Alvarion Ltd. (ALVR)
PennyTrader Publisher, Bull Warrior Stocks, PennyInvest, HotOTC, MadPennyStocks, StockRich, and StockEgg reported earlier on Alvarion Ltd. (ALVR), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Based in Tel Aviv, Israel, Alvarion Ltd. provides optimized wireless broadband solutions. These solutions address the connectivity, coverage and capacity challenges of telecommunications operators, smart cities, security, and enterprise customers. Alvarion bases their solutions on multiple technologies across licensed and unlicensed spectrums. The Company has a multi-dimensional portfolio - multiple frequencies, networks, applications, topologies, as well as environments.
Alvarion has RAN expertise - from standards development to specialized applications. In addition, the Company has years of field experience in relevant technologies including Wi-Fi and 4G. Alvarion has extensive deployments with over three million wireless broadband links deployed globally.
Their CPE device portfolio enables an easy, fast roll out of new and reliable devices, an array of services and true mobility for any 4G wireless network. Their product portfolio includes 4Motion®. This is a complete end-to-end Mobile WiMAX offering. 4Motion® provides operators with open network solutions for promoting long-term business competitiveness in the highly demanding market of wireless broadband services.
Alvarion has their Star Management Suite. This Suite is a complete, field-proven, carrier-class set of tools based on Alvarion's premier WiMAX technologies that helps service providers cost-effectively manage WiMAX deployments, roll out new services, and maintain high service levels. The Company's product portfolio also includes BreezeACCESS®, BreezeCELL™, BreezeCOMPACT, BreezeMAX®, BreezeMAX® Extreme, BreezeNET®, and BreezeULTRA. In addition, their portfolio includes WALKair®, WavioNet, WBS, WBSn, and WCT.
Today, Alvarion announced significant enhancements to their Alvarion Partner Program & Portal. These include new partnership options, online certifications, incentives, deployment modulation tools and more. The design of all of these is to provide a broad spectrum of business development opportunities and resources to deliver a distinct sales advantage, further ensuring Partner success. The Company's Partner Program provides focused benefits to three types of go-to-market partners - Channel Partners, Alliance Partners and Distributors.
Furthermore, Alvarion is launching a distinctive Expert Partner program designed for highly specialized system integrators that demonstrate expertise in deploying complex wireless broadband networks in specific vertical markets. They also launched a Consultant program. It enables consultants to enjoy in-depth knowledge of products, solutions and use the tools, without any commercial commitment or requirement; this preserves professional objectivity.
Alvarion Ltd. (ALVR), closed Wednesday's session at $0.4258, up 2.36%, on 105,174 volume with 57 trades. The average volume for the last 60 days is 214,051 and the stock's 52-week low/high is $0.17/$0.42.
Moneta Porcupine Mines, Inc. (MPUCF)
We are reporting on Moneta Porcupine Mines, Inc. (MPUCF), here at the QualityStocks Daily Newsletter.
Based in Timmins, Ontario, Moneta Porcupine Mines, Inc. engages in the exploration and development of mineral resources in Canada. They hold a 100 percent interest in 5 core gold projects strategically located along the Destor Porcupine Fault Zone in the world class Timmins Camp with more than 85 million ounces of past gold production. There is first-rate infrastructure including paved highway access, water, electricity, a skilled labor force, and nearby mills. Moneta Porcupine Mines' shares trade on the OTC Pink Current Information (MPUCF) and on the Toronto Stock Exchange (ME.TO).
The Company's land position is one of the largest - after three gold producers. This includes the highly prospective Golden Highway Project. It covers 12 kilometers of a volcanic/sedimentary belt along the Destor Porcupine Fault Zone and currently hosts a NI 43-101 resource estimate of 1,091,000 ounces indicated (31. 1 Mt at 1.09 g/t Au) plus 3,204,000 ounces inferred (83. 3 Mt at 1.20 g/t Au), clustered within four kilometers.
The core projects are the Golden Highway Camp and the Porcupine Gold Camp. The Golden Highway Camp includes Windjammer; Southwest Zone; 55 Zone; Dyment 3; Western Zone; Landing/Twin Creeks, and Last Chance. The Porcupine Gold Camp includes Nighthawk Lake; North Tisdale; Kayorum, and West Timmins/Denton Thornloe.
At the beginning of November, Moneta Porcupine Mines announced results from a National Instrument 43-101 Preliminary Economic Assessment (PEA) on their 100 percent owned Golden Highway Project with a 24.4 percent IRR (Internal Rate of Return) and $748M NPV (Net Present Value). The results of the PEA demonstrate the potential technical and economic viability of establishing a new gold mine and mill complex on the Property.
Yesterday, Moneta Porcupine Mines announced the appointment of Mr. Roger Aubertin, P.Eng to the position of Vice President, Exploration for the Company. In addition, Mr. Aubertin will serve as a Qualified Person for the Company as defined under National Instrument 43-101. He most recently held the position of Exploration and Site Project Manager at Detour Gold Corp.
Moneta Porcupine Mines, Inc. (MPUCF), closed Wednesday at $0.273, up 8.76%, on 283,950 volume with 59 trades. The average volume for the last 60 days is 40,450 and the stock's 52-week low/high is $0.14/$0.3925.
ImmuDyne, Inc. (IMMD)
We are reporting on ImmuDyne, Inc. (IMMD), here at the QualityStocks Daily Newsletter.
Listed on the OTC Pink Current Information, ImmuDyne, Inc. is a leading research and manufacturing biotechnology firm. The Company focuses on the development of immune system enhancing compounds notably the purest, particulate and reliable Beta Glucan derived from yeast. Their Beta Glucan is patented, GMP compliant, as well as GRAS listed. ImmuDyne has their corporate headquarters in Mount Kisco, New York.
The Company has a staff of 34 employees and advisors with a combined experience of more than 70 years in the applied science of Beta Glucan research and development dedicated to support the innate immune system. The Company pioneered the research and manufacturing of Beta Glucan. ImmuDyne has a 20-year record of accomplishment of producing stable high grade Beta Glucan with a consistent production process. They additionally utilize proprietary processes for the production of UltraPure YBG®. The Company's UltraPure Yeast Beta Glucan (YBG®) is a 95 percent pure Beta Glucan, free of yeast by-product and endotoxin.
Beta Glucan is a natural extract; Beta Glucans can be found in the cellulose of plants, the bran of cereal grains, the cell wall of baker's yeast, certain fungi, and bacteria. Beta Glucan derived from mushrooms, oats, or barley has not been known to have the same effects on human health as Beta Glucan derived from yeast. Yeast Beta Glucans are notable for their ability to modulate the immune system.
ImmuDyne's MacroForce Plus C once daily oral capsules contain an exclusive combination of ultra-pure Yeast Beta Glucan and Vitamin C designed to support a normal, healthy immune system. Their Skin Care Essentials Rejuvenating Serum contains patented yeast-derived Beta Glucan and other natural ingredients.
The Company's Management Team consists of experienced financial experts and industry specialists with many years of experience in the life science industry. Chairman Dr. Anthony G. Bruzzese is certified by both the American Board of Internal Medicine and the American Board of Radiology with more than 20 years of practice experience. President and Chief Executive Officer Mr. Mark McLaughlin has a business and financial background. He spent 10 years at Lehman Brothers and three years at Oppenheimer & Company. His career exposed him to raising capital, as well as marketing, business and corporate development.
ImmuDyne, Inc. (IMMD), closed today at $0.18, up 20.00%, on 100 volume with 1 trade. The average volume for the last 60 days is 8,807 and the stock's 52-week low/high is $0.15/$0.22.
New Carolin Gold Corp. (LAD.V)
We are highlighting New Carolin Gold Corp. (LAD.V), here at the QualityStocks Daily Newsletter.
New Carolin Gold Corp. is a Canadian junior-stage mineral exploration and mine development company that lists on the TSX Venture Exchange. They engage in the acquisition, exploration, evaluation and development of 144 sq kms of contiguous mineral claims. These are collectively known as the Ladner Gold Project located along the prospective and under-explored Coquihalla Gold Belt located in southeastern British Columbia. New Carolin Gold's mission is to develop the Coquihalla Gold Belt and to realize the inherent value of this British Columbia gold property. The Company has their headquarters in White Rock, British Columbia.
The Ladner Gold Project includes the Carolin Mine, a former underground small gold producer from 1982 - 1984, the Emancipation Mine (an intermittent small gold producer from 1916 - 1941), the Pipestem Mine (intermittent small gold producer from 1935 - 1937), and several other gold prospects located along 18 kilometers of the Coquihalla Gold Belt.
The Company believes that the real potential of their land package is not only the grade of mineralized material as such, but the grade of mineralized material related to the potential cost of extraction. This weighs favorably given the close proximity to Vancouver and the access to labor, equipment, services and infrastructure, and the fact that the original mine, tailings and mill permits are still valid and controlled by New Carolin Gold. Moreover, substantial historic data and intelligence support the Company's position in respect to growing the historic gold resource that contains approximately 700,000 ounces of gold in the Inferred category.
New Carolin Gold's development strategy on the Coquihalla Gold Belt is to mine (by way of contract miner) the tailings to generate cash flow; drill the area from the Carolin Mine to the McMaster Zone to delineate a potential open pit scenario; continue with metallurgical test work; continue with obtaining additional operational permits, and initiate a Preliminary Economic Assessment (PEA) of the Carolin Mine.
On Monday, New Carolin Gold announced that they entered into a Letter of Intent (LOI) with Shoreline Resource Management Group (SRM), in respect to establishing a tailings gold processing facility at the Carolin Mine in 2013. SRM is a resource management consulting company, which provides Engineering, Procurement, Construction and Management of Operations (EPCM) in the mining sector.
New Carolin Gold Corp. (LAD.V), closed Wednesday's trading session at $0.115, even for the day, on 38,000 volume. The stock's 52-week low/high is $0.07/$0.18.
USA Graphite, Inc. (USGT)
Today we are highlighting USA Graphite, Inc. (USGT), here at the QualityStocks Daily Newsletter.
USA Graphite, Inc. is an exploration company concentrating on the acquisition, exploration and development of premier graphite properties in North America. The Company's objective is to become a United States graphite supplier. USA Graphite has holdings in Nevada; the Company believes these offer considerable potential for the discovery and development of large flake, high-grade graphite, where the exposure of mineralization is at surface and evident at economic depths. USA Graphite has their corporate headquarters in Las Vegas, Nevada.
Graphite and diamonds are the only two naturally formed polymers of carbon. Graphite is fundamentally a two dimensional, planar crystal structure; diamonds are a three dimensional structure. Graphite is an excellent conductor of heat and electricity and has the highest natural strength and stiffness of any material.
The Company has their Blue Wing Mountains Graphite Project in western Pershing County, Nevada. The Blue Wing Mountains are in northwestern Nevada, 23 miles east of the border with Washoe County. Extensive sections of the Project contain abundant chiastolite (andalusite) crystals in a matrix of graphite-rich, pelitic pyroxene-hornfels. (Carr - 2010). This Project comprises 96 lode claims covering 1,985 acres (3.1 miles2).
In November, USA Graphite announced that they appointed Mr. Wayne Y. Yamamoto as President and CEO of the Company. Mr. Yamamoto brings more than 30 years of successful leadership and innovation in the area of commodities trading, development companies and corporate finance. He was the President of Call/Recall - the first company to develop and patent terabyte optical storage technology.
Last week, USA Graphite announced that they acquired a 100 percent stake in the Blue Wing Mountains Graphite property. The financial terms of the transaction consist of approximately $3,000,000 in cash, stock, and a $1,000,000 work program commitment.
The financial terms also include paying a production Net Smelter Royalty (NSR) to NV Minerals equal to 2 percent of the net smelter returns, per the terms and conditions of the Option Agreement. USA Graphite shall have a one-time right to purchase 50 percent of the NSR in the Property for $500,000.
USA Graphite, Inc. (USGT), closed Wednesday's trading session at $0.545, up 12.37%, on 971,135 volume with 396 trades. The average volume for the last 60 days is 9,523 and the stock's 52-week low/high is $0.3086/$1.08.
Texas Wyoming Drilling, Inc. (TWDL)
First Microcap Report reported last week on Texas Wyoming Drilling, Inc. (TWDL), HotStockCafe, OTCPicks, PennyStockRumble, Five Star Stock Picks, Stock Traders Chat did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Texas Wyoming Drilling, Inc. is a diversified mining company whose shares trade on the OTC Pink Current Information. The Company operates as a diversified gold, mineral, and rock mining enterprise. Texas Wyoming Drilling's wholly owned subsidiary is Legacy Rock, Inc. Through their Legacy Rock Division, the Company is currently concentrating on gold and precious metals, as well as calcium carbonate and decorative rock. Incorporated in Delaware; Texas Wyoming Drilling (TWDL) is based in Las Vegas, Nevada.
Their projects include the Yellow Jacket Mine; it covers approximately 160 acres located in Moapa, Nevada. Another project is the Blue Jacket Mine covering approximately 70 acres located in Nelson, Nevada with gold and silver claims. In addition, TWDL operates the Legacy Rock Calcium Mine, a Calcium Carbonate project.
Today, Texas Wyoming Drilling announced that they signed a contract for continuing financing. The Company's plans are moving in favor of commencing mining towards the Yellow-Jacket 160-acre Placer Project after reviewing the completed Certified Geologist Report done on this property last year. Their plans for the early part of 2013 are to obtain licenses and permits for the Company to begin mining, and a reclamation bond for the Yellow Jacket Property. Highly significant gold and platinum deposits as well as rare earths have undergone identification and are ready to be mined at the Yellow Jacket site.
In addition, they will commission accountants to complete a Public Company Accounting Oversight Board (PCAOB) audit (the Company has already retained a PCAOB accountant to certify the audit), and a lawyer to complete the Form 10 application to move the company to the OTCQB. The Company's goal is to apply for this designation by the first quarter of 2013.
TWDL's Legacy Rock division continues to experience strong sales of calcium carbonate and decorative rock. This week, they announced a marketing agreement with a global broker with ties to China and the Philippines, France and Korea. With his expert ties he has with top government officials in these countries, TWDL anticipates a large order of Calcium in the very near future. TWDL signed a Consultant Agreement with this firm (Paradigm Three) in Manila. They will represent TWDL to end users in these countries.
Texas Wyoming Drilling, Inc. (TWDL), closed Wednesday's trading session at $0.0114, up 8.57%, on 220,127 volume with 15 trades. The average volume for the last 60 days is 278,253 and the stock's 52-week low/high is $0.0035/$0.06.
Baristas Coffee Company, Inc. (BCCI)
FeedBlitz, PennyStockNewsletter.info, CandlestickPicks, Psycho Penny Stocks, Breaking Bulls, and Marquee Penny Stocks reported earlier on Baristas Coffee Company, Inc. (BCCI), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Baristas Coffee Company, Inc. is a drive-thru espresso company in the Northwest of the United States. Baristas offers their customers hot and cold beverages - specializing in specialty coffees, blended teas, as well as other custom drinks. Additionally, they offer smoothies, fresh-baked pastries and other confections. Baristas Coffee Company lists on the OTC Pink Current Information. The Company has their headquarters in Kent, Washington.
In season, Baristas adds beverages including hot apple cider, hot chocolate, frozen coffees, and more. The Company also earns revenue through promoting and selling Baristas merchandise. This includes calendars, mugs, t-shirts and hats. Baristas locations are Company owned as well as franchised. The Company established to create a national brand of drive-thru espresso stands. They are accomplishing this by acquiring established businesses that fit their model, opening new locations, and by franchising.
Baristas employs and promotes attractive female baristas trained to interact with the customer to maximize sales and prepare premier beverages. All baristas wear an assortment of appealing costumed-themed attire. Currently, Baristas Coffee Company can be found in six greater Seattle area locations as well as in Arizona, Texas, Florida, and Montana.
In October, Baristas announced that the Baristas brand continues to grow with the launch of Coffee Ice Creams. The Company announced that "Barista Coffee Creations" an indulgent collection of coffee ice cream, featuring classic flavors such as "Caramel Cappuccino" and new specialty creations including "Coconut Cafe Latte" have been finalized for distribution. The Company's intention is to develop additional flavors and forms of their "Baristas Coffee Creations" that will be available after the launch of these first two flavors.
As a strategy, the product launch will allow Baristas a suitable test phase while establishing a strong local foothold in the New York metropolitan area. The product launch will allow the time required to add new products to the line up. The building towards the summer season will put Baristas Coffee Company in full swing well ahead of the spring/summer rush. This will allow them to get the product on the shelves now and to start taking purchase orders for delivery for the beginning of 2013.
Baristas Coffee Company, Inc. (BCCI), closed Wednesday's session at $0.017, up 8.97%, on 367,846 volume with 14 trades. The average volume for the last 60 days is 342,832 and the stock's 52-week low/high is $0.01/$0.165.
TMM, Inc. (TMMI)
SmallCapVoice reported earlier on TMM, Inc. (TMMI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
TMM, Inc. owns outright, VDK SoftVideo fractal compression technology that utilizes fractal video compression and decompression algorithms originally licensed from Iterated System, Inc. Currently, the Company is integrating this technology with their TRUDEF™ suite of products. Demonstrations will be available upon the completion of TRUDEF™'s next build update. TMM lists on the OTC Pink Current Information; the Company has their headquarters in Wilmington, Delaware.
TMM develops digital video compression technology that provides end-to-end workflow and distribution solutions for cinema, sports, mobile, streaming media, cable, medical imaging, security, defense, space exploration and education. The Company's TRUDEF™ fractal technology offers users enhanced image quality, reduced bandwidth utilization, as well as digital media storage requirements.
TRUDEF™ is the successor of TMM's VDK SoftVideo™ fractal compression products developed in the 1990's. TRUDEF™ is under active development to meet the demands of the growing high definition video market. Fractal compression has the ability to decompress images into larger resolutions than the original while maintaining a high level of image quality.
Last week, TMM announced the completion of their first version of the Microsoft Media Foundation 2012 library supporting TRUDEF™ Fractal Video playback in Windows Vista, Windows 7 and Windows 8. TRUDEF™ Fractal video can now be played in Microsoft's stand-alone Windows Media Player, WMP Plugins for IE9, Firefox and Google Chrome browsers.
The Company's development team continues their dedication to make TRUDEF a top down solution for the video industry. This is from Production/Post Production, Archiving, Digital Cinema, and Blu-ray, to Broadcasting and Internet Streaming.
In addition, last week, TMM announced the appointment of Mr. Thomas Mackie to their Advisory Board, effective December 1, 2012. Mr. Mackie is the President of G-Force Leadership, LLC, a consulting company that provides program management solutions, leadership training, business development and technical expertise to commercial corporations and government organizations. He founded the company in 2008.
TMM, Inc. (TMMI), closed Wednesday's trading at $0.25, even for the day, on 327,791 volume with 44 trades. The average volume for the last 60 days is 198,687 and the stock's 52-week low/high is $0.029/$0.30.
Viscount Systems, Inc. (VSYS)
The QualityStocks Daily Newsletter would like to spotlight Viscount Systems, Inc. (VSYS). Today, Viscount Systems, Inc. closed trading at $0.057, up 14.00%, on 5,500 volume with 1 trade. The stock’s average daily volume over the past 60 days is 40,353, and its 52-week low/high is $0.0302/$0.07.
Viscount Systems, Inc. (VSYS) designs, manufactures, and services access control and security products such as door access control systems and emergency communications systems. The company's products have been installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices.
Designing security systems since 1969, the company has developed strategic working relationships with leading equipment vendors to support its continued profitability and growth. Viscount has been consistently profitable for nearly 15 years and currently generates annual revenues of approximately $5 million.
Five hundred dealers help distribute Viscount's existing products throughout North America. This distribution network is not static as the company constantly pursues additional sales channels. Products are advertised in various print publications and regularly displayed at tradeshows as well. Direct marketing via training seminars also helps drive sales.
Viscount's management team has more than 60 years of combined experience in the development and production of electronic door control and telecommunication systems. Under this leadership, the SIA Convergence Solution of the Year accolade and Platinum Award for Emergency Response and Gold Award for Access Control at the Government Security Awards (GOVSEC) for 2011 have been presented to the company. Disclaimer
Viscount Systems, Inc. Company Blog
Viscount Systems, Inc. News:
Viscount Announces Completion of $500,000 Private Placement
Viscount Systems Wins Contract with Phoenix Sky Harbor Sky Train
Viscount Systems Partners with Evolis to Provide Visitor Management Solutions
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.275, up 10.00%, on 447,889 volume with 115 trades. The stock’s average daily volume over the past 60 days is 127,539, and its 52-week low/high is $0.161/$0.68.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp to Participate in Fifth Annual LD Micro Conference
International Stem Cell Corporation Announces Significant Progress Towards Clinical Development
International Stem Cell Corp Subsidiary Lifeline Skin Care Announces Latest Product Launch
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $9.19, up 1.10%, on 86,917 volume with 76 trades. The stock’s average daily volume over the past 60 days is 46,048, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
TNI BioTech Inc., and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
Dr. Henry "Skip" Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.23, off by 0.04%, on 105,174 volume with 57 trades. The stock’s average daily volume over the past 60 days is 214,051, and its 52-week low/high is $0.17/$0.42.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium Announces Patent Award For Rights To Gene Therapy for Coronary Heart Disease, Resolves Long-standing IP Competition
Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
Mark Luden, President and CEO of The Guitammer Company, was recently introduced by Singular Research, a trusted supplier of performance-based research on micro-cap companies. Mark Luden had presented at Singular’s 7th Annual “The Best Of The Uncovereds” conference, making a big hit with a product demonstration.
The Guitammer Company, based in Ohio, is a leader in low frequency sound products and technology, with award-winning innovations through their ButtKicker brand, that let users feel low-frequency sound in ways never before possible. The frequencies they work with are below the audible level, so the user doesn’t hear the sound, but actually feels it. As a result, users are immersed in the sound-feeling experience, whether at home or elsewhere, without having to worry about annoying others or damaging their hearing. Their products are now used around the world by such entertainment and theater companies as AMC, IMAX, and Disney, and by world famous musicians, as well as with in-home theaters and advanced car audio systems.
Mr. Luden began his presentation by describing how his company is in the process of changing the way that people watch sports and other broadcast entertainment. The company has the platform and broadcast technology to allow users to actually feel the action, revolutionizing the experience much like Dolby has done with their patents on surround sound or TiVo has done with television viewing.
Mr. Luden went on to describe the company’s key strengths, both internally and in the marketplace.
The Guitammer Company effectively has two growth platforms: their established core business of making and selling their unique low-frequency technology based products, and now their emerging low frequency broadcasting technology called ButtKicker Live! The latter is currently being tested in sports arenas and other settings, and offers the potential of significant recurring revenue.
Revenues from their core business operations for fiscal 2012 already exceed total fiscal 2011 sales of $1.3 million, and are backed up by gross margins of over 40%, well above the industry average. And the company’s new ButtKicker Live! technology offers significant opportunity for high-margin recurring revenue across multiple channels, with initial revenues expected in fiscal 2013. Overall, the company expects to pass the break-even point by the first quarter of fiscal 2013. To fund their growth strategy, the company has completed a private placement raising $2.1 million in growth capital, extinguishing nearly $1.5 million in debt, and demonstrating the confidence the investment community has in Guitammer’s plans and potential.
ButtKicker brand products have definite competitive advantages:
• They provide a similar entertainment experience at a significantly lower cost than motion-based competition
• They include a patented “floating magnetic suspension system”
• They offer greater low frequency range (5-200 Hz) than any competitive device, representing a powerful immersive bass experience for consumers
• They provide smooth and accurate musical response, without resonant frequency peaks or hot spots
• They are virtually indestructible and maintenance-free due to superior design characteristics, as verified by years of real-world use across the globe
• Since the frequencies are not audible, there is no need to have sound levels annoyingly or even dangerously high
• They are the only tactile products designed for mass market consumer electronics distribution, with the appropriate packaging, pricing, and all-in-one kit ease of use
SciClone Pharmaceuticals announced that in the annual competition sponsored by the Tag and Label Manufacturers Institute (TLMI), its newly created anti-counterfeiting Pharma-Comb Void label for ZADAXIN has won the prestigious “Innovator Award.”
Created for SciClone by Schreiner MediPharm, a developer and manufacturer of pharmaceutical specialty labels based in Germany, the ZADAXIN label has been designed based on an innovative multipart concept to ensure product safety and security, as well as to counteract the illegal practice of refilling previously used medicine vials.
The serious problem of drug counterfeiting is a challenge facing the pharmaceutical industry, public health and regulatory authorities throughout the world. This problem is also a threat to patient safety, compromising the supply and efficacy of medical interventions as well as damaging the commercial viability of important drug therapies. Committed to ensuring patient safety and security for all its marketed products, SciClone intends to continue implementing an aggressive anti-counterfeiting strategy for ZADAXIN, working collaboratively with agencies and health authorities to fight the crime of illegal medication trafficking.
During its initial use, the ZADAXIN Pharma-Comb Void label is designed to be functionally destroyed. The inscriptions “Opened” and “Used” appear in two indicator fields when the label’s tear strip – which also encircles the closure cap – is removed. This design is intended to make it virtually impossible to reuse a glass container with an original label without the fraudulence being detected. The company believes that its Pharma-Comb Void label overcomes the limitations of conventional vials, which can be filled a second time and sold, undetected, as originals – even when equipped with overt security features like holograms or color-shifting inks. The new ZADAXIN label has been created to counteract this practice; it also offers a valuable-added benefit for healthcare professionals, which is that a detachable part is released when the label is opened, serving to mark the syringe accordingly.
China-focused but based in the United States, SciClone Pharmaceuticals is a specialty pharmaceutical company with a portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory and central nervous system disorders. The company’s ZADAXIN (thymalfasin) has been approved in more than 30 countries and can be used to treat hepatitis B, hepatitis C and certain cancers, as well being used as a vaccine adjuvant, according to the legal regulatory approvals. In addition to ZADAXIN, SciClone also markets around 14 products in China, mostly partnered, including Depakine, Tritace, Stilnox (marketed as Ambien in the U.S.) and Aggrastat. The company is additionally pursuing the registration of various other therapeutic products in China.
For more information, visit the company’s Web site at www.sciclone.com
AXION International Holdings president and CEO Steve Silverman later this week is scheduled to attend a ribbon cutting ceremony for the opening of the first bridge in California to be constructed out of AXION’s STRUXURE™ building products.
AXION, a green technology company transforming waste plastics into structural building materials, provided its STRUXURE building material for the 25-foot pedestrian bridge in Santa Rosa Valley, Calif. The 25-foot pedestrian bridge is the first known bridge on the West Coast with a superstructure and fencing made of recycled plastic. Though made of 100% recycled consumer and industrial plastics, STRUXURE is compatible with traditional building materials, enabling the bridge’s engineer to use timber for the bridge’s decking.
The bridge was designed by VCE Service bridge engineer John Dickerson, who selected STRUXURE for the bridge’s superstructure and fencing because of its structural thermoplastic material, which is non-toxic, does not leach or warp, and is completely recyclable at the end of its functional life.
“I plan to use the plastic material for projects in and around the ocean, where steel corrodes, concrete cracks, and wood warps and eventually erodes because of insects. You couldn’t use a better material around saltwater because it’s totally immune to anything saltwater can possibly do to it. The applications for this material are almost endless,” Dickerson stated in the press release.
A ribbon cutting and dedication ceremony for the bridge is scheduled to take place at Friday, December 7.
“We are very proud of what we’ve achieved in bringing a high-performance, sustainable building material into the California market that leads the world in its dedication to the environment,” Silverman stated. “STRUXURE offers a superior long-term value to communities and repurposes plastic waste into structural building materials. I am honored to be a part of this ribbon cutting ceremony.”
For more information, visit www.AXIH.com
Vanguard Energy, the drilling and production company focused on established fields in southeast Texas, reported today that the third party reserve engineering firm used for certification purposes has upwardly revised the final proved reserves total by 17% to 725,882 bbls, firmly reinforcing the value of Vanguard’s flagship Batson Dome Field, as well as the company’s extant/new drilling program(s).
This is an even larger jump when compared to last year’s exit totals (reserves are up 20% since Sept 30), a track record that clearly shows VNGE’s capacity to grow reserves through circumspect development. We are talking a PV-10 value of some $43.4M on that reserve total, up 21% from the valuation previously reported (Nov 19, $35.8M), or up a handsome 36% since the end of last year (Sept 30).
President of VNGE, Warren Dillard, spoke of how good the new figures looked to shareholders, especially so soon after the previous report, which was also really positive news. Dillard cited the $3.40 or more in PV-10 valuation per share of stock being generated as a current sign of Vanguard’s good health, as well as showcasing the massive amount of undeveloped category reserves within the larger proven total, something which gives investors an obvious road sign for future growth at Batson. Dillard was very enthusiastic about the company’s planned drilling/development program, telegraphing the raging drive at VNGE to tap more fully into that huge wealth of undeveloped oil.
With some 48.5k bbls of production out of Batson this year and a whopping reserve replacement rate of 270% (based on finalized proven reserves total from today’s figures), VNGE has captured a tremendous value proposition for investors with a bright future as the planet’s taste for oil continues to heat up. A full 58% of the proven reserves total is in the undeveloped category, with only 30% currently PDP (proved developed producing, the remaining 12% is in the developed non-producing category) and this huge amount of untapped growth potential is a very bold indicator to markets of VNGE’s future performance, especially as the newest drilling program ramps up.
The plan is to put in two more wells at Batson before the close of the calendar year, and VNGE is proceeding apace of expectations with the first well already spudded this week near the last successful completion and a second getting ready to go in on the recently acquired Hull-Daisetta field acreage. All perfectly in line with the company’s industry projections really, as VNGE moves to compensate for the domestic economy’s insatiable appetite for energy, even as China emerges, the new king of global energy consumption.
VNGE cares a great deal about shareholder value and this is made evident by the consistent engagement of an independent reservoir engineering company to audit the company’s proven reserves and determine overall economic value of the holdings at the end of each year (based on total potential production of proven reserves discounted at an annualized 10% rate, in accordance with standard SEC reporting praxis). It is noteworthy that the increase reported today in proven reserves has been achieved solely through further intelligent development of existing acreage by the company. The replacement rate itself speaks volumes about the potential of VNGE’s acreage footprint, as the reserve growth reported today already factors in oil depletion from preceding production.
Yes, Vanguard continues to prove themselves capable of steadily growing their reserves through shrewd development, while continuing to churn out solid production and acquisition metrics. The company is on the front lines of helping to secure U.S. independence from foreign oil imports by ably targeting and developing low-risk wells close to existing production within its primary target area of Texas
For more information on Vanguard Energy, visit www.VanguardEnergyCorp.com
Today's Top 3
Investor News Source
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report With the Securities and Exchange Commission
- Cardium Therapeutics, Inc. (CXM) Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
- DoMark International, Inc. (DOMK) Subsidiary and Infrared/Solar Apple Accessory Leader, SolaWerks™, Launches New Website
- The Guitammer Company Inc. (GTMM) Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
- GlobalWise Investments, Inc. (GWIV) Reports Third Quarter 2012 Financial Results and Provides Revised Fiscal 2012 Guidance
- International Stem Cell Corp. (ISCO) Announces Significant Progress Towards Clinical Development
- Loans4Less.com, Inc. (LFLS) Reports Financial Results for the Third Quarter of 2012
- TNI BioTech Inc. (TNIB) Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
- Viaspace, Inc. (VSPC) Board Chairman and CEO Conduct Interview With The Green Baron Report
- VistaGen Therapeutics, Inc. (VSTA) Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System -- LiverSafe 3D™